Tag Archives: Zimmer Biomet Holdings

Zimmer Biomet Holdings (ZBH) Gets a Buy Rating from Robert W. Baird

Robert W. Baird analyst Jeff Johnson maintained a Buy rating on Zimmer Biomet Holdings (ZBH – Research Report) on September 3. The company’s shares closed last Monday at $141.00. According to TipRanks.com, Johnson is a 5-star analyst with an average

Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH), Bluebird Bio (NASDAQ: BLUE) and Cortexyme (NASDAQ: CRTX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zimmer Biomet Holdings (ZBH – Research Report), Bluebird Bio (BLUE – Research Report) and Cortexyme (CRTX – Research Report) with bullish sentiments.

Zimmer Biomet Holdings (ZBH) Has a New Rating from Raymond James

Zimmer Biomet Holdings (ZBH – Research Report) received a Buy rating and a $170.00 price target from Raymond James analyst Lawrence Keusch today. The company’s shares closed last Wednesday at $148.74. According to TipRanks.com, Keusch is a 4-star analyst with

Needham Believes Zimmer Biomet Holdings (NYSE: ZBH) Won’t Stop Here

Needham analyst Michael Matson assigned a Buy rating to Zimmer Biomet Holdings (ZBH – Research Report) today and set a price target of $185.00. The company’s shares closed last Thursday at $151.36, close to its 52-week high of $165.15. According

Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH), BioMarin Pharmaceutical (NASDAQ: BMRN) and Deciphera Pharmaceuticals (NASDAQ: DCPH)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Zimmer Biomet Holdings (ZBH – Research Report), BioMarin Pharmaceutical (BMRN – Research Report) and Deciphera Pharmaceuticals (DCPH – Research Report). Zimmer Biomet Holdings (ZBH) Leerink

Zimmer Biomet Holdings (ZBH) Gets a Buy Rating from BTIG

In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Zimmer Biomet Holdings (ZBH – Research Report), with a price target of $139.00. The company’s shares closed last Tuesday at $130.64. According to TipRanks.com, Zimmerman is